The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines

被引:49
作者
Turesky, RJ [1 ]
机构
[1] Natl Ctr Toxicol Res, Div Chem, Jefferson, AR 72079 USA
关键词
heterocyclic aromatic amines; xenobiotic metabolism enzymes; polymorphisms; cancer;
D O I
10.2174/1389200043489036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
More than twenty heterocyclic aromatic amines (HAAs) have been identified in grilled meats, Fish, poultry, and tobacco smoke condensate. HAAS are carcinogens and induce tumors at Multiple Sites in experimental laboratory animals. Because of the widespread occurrence of HAAs in foods, these chemicals may contribute to the etiology of several common human cancers that are associated with frequent consumption of grilled meals including colon, rectum, prostate, and breast. HAAs require metabolism in order to exert their genotoxic effects. Metabolic activation occurs by N-hydroxylation, a reaction catalyzed by cytochromes P450 (CYP). Sonic N-hydroxy-HAA metabolites may directly react with DNA. but further metabolism by N-acetyltransferases (NATs) or sulfotransferases (SULTs) may occur to form highly reactive N-acetoxy or N-sulfonyloxy esters that readily react with DNA bases. The N-acetoxy ester of the HAA 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) is detoxified by glutathione S-transferases (GSTs), which catalyze the reduction of the reactive intermediate back to the parent amine. Sonic HAAs also undergo detoxification through conjugation reactions with the phase II enzymes Such as UDP-glucuronosyltransferases (UGTs) or SULTs to form stable, polar products that are readily eliminated. All of these xenobiotic metabolism enzyme systems (XMEs) display common genetic polymorphisms, which may affect protein expression, protein stability, catalytic activity, and thus, the biological potency of these procarcinogens. In this review, the roles of common genetic polymorphisms of XMEs involved in HAA metabolism and cancer risk are discussed.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 164 条
[1]   Expression in human prostate of drug- and carcinogen-metabolizing enzymes:: association with prostate cancer risk [J].
Agúndez, JAG ;
Martínez, C ;
Olivera, M ;
Gallardo, L ;
Ladero, JM ;
Rosado, C ;
Prados, J ;
Rodriguez-Molina, J ;
Resel, L ;
Benítez, J .
BRITISH JOURNAL OF CANCER, 1998, 78 (10) :1361-1367
[2]   Genetic polymorphism of CYP1A2 in ethiopians affecting induction and expression: Characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1 [J].
Aklillu, E ;
Carrillo, JA ;
Makonnen, E ;
Hellman, K ;
Pitarque, M ;
Bertilsson, L ;
Ingelman-Sundberg, M .
MOLECULAR PHARMACOLOGY, 2003, 64 (03) :659-669
[3]  
Alexander J., 1995, HETEROCYCLIC AMINES, P59
[4]  
Ambrosone CB, 1998, INT J CANCER, V75, P825, DOI 10.1002/(SICI)1097-0215(19980316)75:6&lt
[5]  
825::AID-IJC2&gt
[6]  
3.0.CO
[7]  
2-X
[8]   Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer [J].
Bamber, DE ;
Fryer, AA ;
Strange, RC ;
Elder, JB ;
Deakin, M ;
Rajagopal, R ;
Fawole, A ;
Gilissen, RAHJ ;
Campbell, FC ;
Coughtrie, MWH .
PHARMACOGENETICS, 2001, 11 (08) :679-685
[9]   The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs [J].
Barrington K.J. .
BMC Pediatrics, 1 (1)
[10]   A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene:: association with tardive dyskinesia in schizophrenia [J].
Basile, VS ;
Özdemir, V ;
Masellis, M ;
Walker, ML ;
Heltzer, HY ;
Lieberman, JA ;
Potkin, SG ;
Alva, G ;
Kalow, W ;
Macciardi, FM ;
Kennedy, JL .
MOLECULAR PSYCHIATRY, 2000, 5 (04) :410-417